|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 532.81 USD | -0.31% |
|
+0.59% | +14.13% |
| Capitalization | 119B 103B 92.71B 88.95B 162B 10,946B 170B 1,096B 439B 5,249B 447B 438B 18,774B | P/E ratio 2026 * |
17.5x | P/E ratio 2027 * | 16x |
|---|---|---|---|---|---|
| Enterprise value | 166B 144B 130B 124B 227B 15,296B 237B 1,531B 614B 7,335B 625B 611B 26,234B | EV / Sales 2026 * |
2.12x | EV / Sales 2027 * | 1.99x |
| Free-Float |
71.58% | Yield 2026 * |
0.57% | Yield 2027 * | 0.6% |
Last Transcript: HCA Healthcare, Inc.
| 1 day | -0.31% | ||
| 1 week | +0.59% | ||
| Current month | +0.59% | ||
| 1 month | +6.20% | ||
| 3 months | +9.82% | ||
| 6 months | +27.44% | ||
| Current year | +14.13% |
| 1 week | 522.49 | 547.43 | |
| 1 month | 495 | 552.9 | |
| Current year | 461.44 | 552.9 | |
| 1 year | 310.18 | 552.9 | |
| 3 years | 215.96 | 552.9 | |
| 5 years | 164.47 | 552.9 | |
| 10 years | 58.38 | 552.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samuel Hazen
CEO | Chief Executive Officer | 64 | 31/12/2018 |
Mike Marks
DFI | Director of Finance/CFO | 56 | 30/04/2024 |
Jon Foster
PSD | President | 63 | 30/09/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Frist
CHM | Chairman | 58 | 25/04/2019 |
William Frist
BRD | Director/Board Member | 56 | 31/12/2008 |
Samuel Hazen
BRD | Director/Board Member | 64 | 09/09/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.31% | +0.59% | +61.38% | +111.91% | 119B | ||
| -0.98% | -2.48% | +17.47% | -2.37% | 99.13B | ||
| +0.71% | -8.19% | +16.16% | +91.99% | 30.53B | ||
| -2.27% | -6.73% | +6.58% | +17.27% | 22.22B | ||
| +1.89% | +6.18% | -11.38% | -2.30% | 22.58B | ||
| -2.34% | -5.99% | +13.47% | +45.70% | 21.89B | ||
| -1.84% | -1.02% | +85.86% | +311.37% | 20.61B | ||
| +0.73% | -4.69% | +36.50% | +54.26% | 16.08B | ||
| -0.55% | +0.08% | -10.31% | +9.03% | 12.54B | ||
| -2.19% | -6.53% | +11.58% | +56.66% | 11.77B | ||
| Average | -0.72% | -2.88% | +22.73% | +69.35% | 37.64B | |
| Weighted average by Cap. | -0.61% | -1.96% | +32.10% | +67.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.68B 67.84B 61.24B 58.76B 107B 7,231B 112B 724B 290B 3,468B 295B 289B 12,402B | 82.51B 71.14B 64.22B 61.62B 112B 7,583B 118B 759B 304B 3,636B 310B 303B 13,005B |
| Net income | 6.82B 5.88B 5.31B 5.1B 9.29B 627B 9.73B 62.8B 25.16B 301B 25.61B 25.07B 1,076B | 7.14B 6.16B 5.56B 5.34B 9.73B 657B 10.18B 65.74B 26.34B 315B 26.82B 26.24B 1,126B |
| Net Debt | 47.33B 40.81B 36.84B 35.35B 64.46B 4,350B 67.46B 436B 174B 2,086B 178B 174B 7,461B | 45B 38.8B 35.03B 33.61B 61.29B 4,136B 64.14B 414B 166B 1,983B 169B 165B 7,093B |
Employees
275,000
Calendar
03-17 -
Ex-dividend date - 0.78 USD
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 532.81 $ | -0.31% | 753,151 |
| 05/03/26 | 534.47 $ | -1.83% | 1,097,943 |
| 04/03/26 | 544.41 $ | +0.48% | 930,563 |
| 03/03/26 | 541.80 $ | +1.67% | 797,639 |
| 02/03/26 | 532.92 $ | +0.61% | 816,440 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
532.81USD
Average target price
541.52USD
Spread / Average Target
+1.64%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HCA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















